Obesity Medicine 2025 - Investigational Anti-Obesity Drugs in the Pipeline (Recorded)

This presentation explores emerging investigational therapies designed to combat obesity. Attendees will gain insights into the mechanisms of action driving these innovative drugs, as well as a critical evaluation of the latest clinical trial data, including efficacy, safety, and clinical outcomes. Additionally, the session will address how these future therapies could complement existing anti-obesity medications, paving the way for more effective and integrated treatment strategies.

CME/CE Expiration Date: 4/27/28

*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

 

 

 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the commensurate amount with the extent of their participation in the activity.
Course opens: 
04/29/2024
Course expires: 
04/27/2028
Cost:
$25.00

Harold E. Bays, MD, MFOMA, FTOS, FACC, FNLA, FASPC

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the commensurate amount with the extent of their participation in the activity.

Price

Cost:
$25.00
Please login or register to take this course.

Required Hardware/software

For best user experience we recommend using a computer to complete this course.